Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00856986

Public ClinicalTrials.gov record NCT00856986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 5:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes. A 26 Week, Randomised, Open-label, Parallel-group, Multicentre, Multinational Trial With a 26 Week Extension

Study identification

NCT ID
NCT00856986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
987 participants

Conditions and interventions

Interventions

  • insulin detemir Drug
  • liraglutide Drug
  • metformin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 84 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2009
Primary completion
Mar 31, 2010
Completion
Oct 31, 2010
Last update posted
Mar 7, 2017

2009 – 2010

United States locations

U.S. sites
60
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Novo Nordisk Investigational Site Alexander City Alabama 35010
Novo Nordisk Investigational Site Birmingham Alabama 35294
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Fullerton California 92835
Novo Nordisk Investigational Site Inglewood California 90301
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Los Gatos California 95032
Novo Nordisk Investigational Site Montclair California 91763
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Waterbury Connecticut 06712
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Clearwater Florida 33765
Novo Nordisk Investigational Site Jupiter Florida 33458-7200
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site Miami Florida 33169
Novo Nordisk Investigational Site Atlanta Georgia 30308-2253
Novo Nordisk Investigational Site Decatur Georgia 30033
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Savannah Georgia 31405
Novo Nordisk Investigational Site Chicago Illinois 60616
Novo Nordisk Investigational Site Quincy Illinois 62301
Novo Nordisk Investigational Site Chicago Heights Indiana 60411
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Madisonville Kentucky 42431
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Methuen Massachusetts 01844
Novo Nordisk Investigational Site St Louis Missouri 63104
Novo Nordisk Investigational Site New Hyde Park New York 11042
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site Syracuse New York 13210
Novo Nordisk Investigational Site The Bronx New York 10461-2665
Novo Nordisk Investigational Site Charlotte North Carolina 28277
Novo Nordisk Investigational Site Durham North Carolina 27710
Novo Nordisk Investigational Site Cincinnati Ohio 45226
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Danville Pennsylvania 17822
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152
Novo Nordisk Investigational Site State College Pennsylvania 16801
Novo Nordisk Investigational Site Willkes Barre Pennsylvania 18702
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Memphis Tennessee 38119
Novo Nordisk Investigational Site Corpus Christi Texas 78412
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75235-6233
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Plano Texas 75075
Novo Nordisk Investigational Site Orem Utah 84058
Novo Nordisk Investigational Site Richmond Virginia 23249
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 173 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00856986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2017 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00856986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →